Market cap
₹209 Cr
Revenue (TTM)
₹97 Cr
P/E Ratio
10.9
P/B Ratio
1
Div. Yield
0.3 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 11.87 | 57.39 | -5.35 | 8.64 | -0.28 |
| EBIT | -14.79 | 178.79 | 2.90 | 83.96 | 1.08 |
| Net Profit | 3.03 | 110.06 | 2.59 | 41.55 | 6.13 |
| EPS | 3.16 | 110.06 | 7.21 | 42.03 | 6.39 |
| Book Value | -- | -- | 13.36 | 8.84 | 11.71 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-25 | Mar-24 |
| EBIT-Margin
| 13.40 | 12.56 | 16.72 | 21.07 | 17.05 |
| Net Margin
| 14.84 | 13.86 | 18.00 | 19.46 | 17.49 |
| Return on equity
| 8.80 | 8.67 | 8.98 | 12.76 | 9.50 |
| Return on Capital
| 11.64 | 11.23 | -- | 17.04 | 12.48 |
| Return on Assets
| 7.65 | 7.34 | 8.17 | 11.10 | 8.31 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.02 | 0.00 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
17.04
|
12.48
|
5.41
|
7.87
|
|
Peer Median
|
--
|
21.76
|
21.89
|
--
|
17.36
|
ROE
8.98
Lower than Peers by 6.30
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
8.98
|
12.76
|
9.50
|
4.15
|
6.18
|
|
Peer Median
|
15.28
|
17.93
|
16.42
|
--
|
17.35
|
ROA
8.17
Lower than Peers by 2.13
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
8.17
|
11.10
|
8.31
|
3.54
|
5.06
|
|
Peer Median
|
10.30
|
12.81
|
12.32
|
--
|
10.65
|
EBIT Margin
16.72
Lower than Peers by 1.10
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
16.72
|
21.07
|
17.05
|
2.09
|
8.23
|
|
Peer Median
|
17.82
|
18.93
|
21.05
|
--
|
11.27
|
Net Margin
18.00
Higher than Peers by 3.62
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
18.00
|
19.46
|
17.49
|
7.58
|
11.25
|
|
Peer Median
|
14.38
|
14.94
|
15.51
|
--
|
11.45
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
0.00
|
22.75
|
21.23
|
11.04
|
14.60
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-5.35
Lower than Peers by 17.42
Year on year growth in net sales
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
-5.35
|
37.47
|
7.09
|
3.32
|
-21.70
|
|
Peer Median
|
12.07
|
10.90
|
13.44
|
--
|
11.49
|
EBIT Growth
2.90
Lower than Peers by 19.06
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
2.90
|
69.87
|
774.24
|
-73.79
|
-55.12
|
|
Peer Median
|
21.96
|
15.01
|
23.50
|
--
|
-1.10
|
Net Profit Growth
2.59
Lower than Peers by 21.95
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
2.59
|
52.99
|
144.97
|
-28.75
|
-33.26
|
|
Peer Median
|
24.54
|
14.80
|
30.12
|
--
|
4.90
|
EPS Growth
7.21
Lower than Peers by 13.07
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
7.21
|
52.99
|
144.97
|
-28.75
|
-33.26
|
|
Peer Median
|
20.28
|
14.27
|
29.02
|
--
|
10.00
|
Book Value Growth
--
--
Year on year growth in book value per share
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
13.36
|
14.66
|
-0.80
|
14.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
0.02
|
--
|
--
|
0.04
|
|
Peer Median
|
0.01
|
0.06
|
0.03
|
--
|
0.18
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
0.02
|
--
|
--
|
0.04
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.48
Higher than Peers by 4.53
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
6.48
|
7.07
|
6.18
|
10.42
|
5.13
|
|
Peer Median
|
1.95
|
1.90
|
2.23
|
--
|
1.72
|
Quick Ratio
5.73
Higher than Peers by 4.26
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
5.73
|
6.68
|
5.57
|
9.36
|
4.41
|
|
Peer Median
|
1.46
|
1.46
|
1.59
|
--
|
1.41
|
Interest Coverage
182.66
Higher than Peers by 163.86
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
182.66
|
333.69
|
--
|
25.30
|
85.02
|
|
Peer Median
|
18.79
|
24.96
|
45.29
|
--
|
24.64
|
Operating Efficiency
Debtors to sales
30.43
Higher than Peers by 8.89
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
30.43
|
29.25
|
33.70
|
29.98
|
50.41
|
|
Peer Median
|
21.54
|
21.77
|
20.10
|
--
|
23.77
|
Asset Turnover
0.41
Lower than Peers by 0.31
Sales / Average Total Assets
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
0.41
|
0.53
|
0.44
|
0.43
|
0.42
|
|
Peer Median
|
0.72
|
0.76
|
0.81
|
--
|
1.05
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
98.13
|
112.59
|
143.76
|
186.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
39.72
|
60.34
|
72.11
|
96.64
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
102.34
|
146.79
|
75.80
|
167.30
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
--
|
35.50
|
26.14
|
140.06
|
115.85
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
10.88
Lower than Peers by 23.09
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
10.88
|
10.37
|
8.40
|
12.69
|
10.08
|
|
Peer Median
|
33.97
|
26.81
|
39.85
|
--
|
26.65
|
Price / Book Value
0.97
Lower than Peers by 3.83
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
0.97
|
1.25
|
0.75
|
0.53
|
0.58
|
|
Peer Median
|
4.80
|
4.65
|
6.11
|
--
|
3.55
|
Dividend Yield
0.34
Lower than Peers by 0.14
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
0.34
|
0.21
|
0.54
|
--
|
--
|
|
Peer Median
|
0.48
|
0.61
|
0.37
|
--
|
0.04
|
EV/EBITDA
4.94
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
4.94
|
4.93
|
3.12
|
3.86
|
4.59
|
|
Peer Median
|
--
|
27.02
|
34.57
|
--
|
17.31
|
Market Cap
209
Lower than Peers by 17,947
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
|---|---|---|---|---|---|
|
Coral Laboratories
|
209
|
251
|
133
|
82
|
91
|
|
Peer Median
|
18,156
|
20,914
|
25,297
|
--
|
474
|